Rhinotussal Saft Retardsuspension
Valsts: Vācija
Valoda: vācu
Klimata pārmaiņas: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
Nosūtīt pieprasījumu.
Aktīvā sastāvdaļa:
Dextromethorphan-poly(styrol-co-divinylbenzol)sulfonat [1:x(y:z)], Carbinoxamin-poly(styrol-co-divinylbenzol)sulfonat [1:x(y:z)], Phenylpropanolamin-poly(styrol-co-divinylbenzol)sulfonat [1:x(y:z)]
Pieejams no:
Pfizer Manufacturing Deutschland GmbH
SNN (starptautisko nepatentēto nosaukumu):
Dextromethorphan poly(styrene-co-divinyl benzene)sulfonate [1:x(y:z)], carbinox amine-poly(styrene-co-divinyl benzene)sulfonate [1:x(y:z)], phenyl propanol amine, poly(styrene-co-divinyl benzene)sulfonate [1:x(y:z)]
Zāļu forma:
Retardsuspension
Kompozīcija:
Dextromethorphan-poly(styrol-co-divinylbenzol)sulfonat [1:x(y:z)] 500.mg; Carbinoxamin-poly(styrol-co-divinylbenzol)sulfonat [1:x(y:z)] 64.mg; Phenylpropanolamin-poly(styrol-co-divinylbenzol)sulfonat [1:x(y:z)] 1700.mg
Autorizācija statuss:
gültig
![Dextromethorphan-poly(styrol-co-divinylbenzol)sulfonat [1:x(y:z)], Carbinoxamin-poly(styrol-co-divinylbenzol)sulfonat [1:x(y:z)], Phenylpropanolamin-poly(styrol-co-divinylbenzol)sulfonat [1:x(y:z)]](/web/img/edge.svg){kind=small}